Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient

Orthopedics

Volumn 34, Issue 11, 2011, Pages

  Lustenberger, David P ^a   Granata, Jaymes D ^a   Scharschmidt, Thomas J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GAIT; GRAFT RECIPIENT; HAND; HAND RADIOGRAPHY; HUMAN; LUNG TRANSPLANTATION; MYCOSIS; PERIOSTITIS; PERIOSTITIS DEFORMANS; PHALANX; RANGE OF MOTION;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; DRUG SUBSTITUTION; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; PERIOSTITIS; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 81255192169     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20110922-35     Document Type: Article

References (20)

1. Grönblad M, Liesi P, Korkala O, Karaharju E, Polak J. Innervation of human bone periosteum by peptidergic nerves. Anat Rec. 1984; 209(3):297-299. (Pubitemid 14088453)
2. Nahar I, Al-Shemmeri M, Hussain M. Secondary hypertrophic osteoarthropathy: new insights on pathogenesis and management. Gulf J Oncolog. 2007; 1(1):71-76.
3. Soriano M, Manchón F. Radiological aspects of a new type of bone fluorosis, periostitis deformans. Radiology. 1966; 87(6):1089-1094.
4. Wang TF, Wang T, Altman R, et al. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients [published online ahead of print October 21, 2009]. Am J Transplant. 2009; 9(12):2845-2850.
5. Chen L, Mulligan ME. Medication-induced periostitis in lung transplant patients: periostitis deformans revisited [published online ahead of print July 22, 2010]. Skeletal Radiol. 2011; 40(2):143-148.
6. Fewtrell L, Smith S, Kay D, Bartram J. An attempt to estimate the global burden of disease due to fluoride in drinking water. J Water Health. 2006; 4(4):533-542. (Pubitemid 44895949)
7. Whyte MP, Essmyer K, Gannon FH, Reinus WR. Skeletal fluorosis and instant tea. Am J Med. 2005; 118(1):78-82. (Pubitemid 40082462)
8. Lung SC, Cheng HW, Fu CB. Potential exposure and risk of fluoride intakes from tea drinks produced in Taiwan [published online ahead of print April 4, 2007]. J Expo Sci Environ Epidemiol. 2008; 18(2):158-166. (Pubitemid 351281025)
9. Joshi S, Hlaing T, Whitford GM, Compston JE. Skeletal fluorosis due to excessive tea and toothpaste consumption [published online ahead of print October 9, 2010]. Osteoporos Int. 2011; 22(9):2557-2560.
10. Kurland ES, Schulman RC, Zerwekh JE, Reinus WR, Dempster DW, Whyte MP. Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res. 2007; 22(1):163-170. (Pubitemid 46032610)
11. Fisher JR, Sievers ML, Takeshita RT, Caldwell H. Skeletal fluorosis from eating soil. Ariz Med. 1981; 38(11):833-835.
12. Klemmer PJ, Hadler NM. Subacute fluorosis: a consequence of abuse of an organofluoride anesthetic. Ann Intern Med. 1978; 89(5 Pt 1):607-611. (Pubitemid 9060010)
13. Meunier PJ, Courpron P, Smoller JS, Briancon D. Niflumic acid-induced skeletal fluorosis: iatrogenic disease or therapeutic perspective for osteoporosis? Clin Orthop Relat Res. 1980; (148):304-309. (Pubitemid 11243099)
14. Rothenberg AB, Berdon WE, Woodard JC, Cowles RA. Hypervitaminosis A-induced premature closure of epiphyses (physeal obliteration) in humans and calves (hyena disease): a historical review of the human and veterinary literature [published online ahead of print October 2, 2007]. Pediatr Radiol. 2007; 37(12):1264-1267. (Pubitemid 350160034)
15. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent [published online ahead of print February 10, 2003]. Clin Infect Dis. 2003; 36(5):630-637. (Pubitemid 36259570)
16. Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. J Clin Pharmacol. 2002; 42(4):395-402. (Pubitemid 34259773)
17. Shanmugam VK, Matsumoto C, Pien E, et al. Voriconazole-associated myositis. J Clin Rheumatol. 2009; 15(7):350-353.
18. Ayub A, Kenney CV, McKiernan FE. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient. J Clin Rheumatol. 2011; 17(2):73-75.
19. Wermers RA, Cooper K, Razonable RR, et al. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy [published online ahead of print January 16, 2011]. Clin Infect Dis. 2011; 52(5):604-611.
20. Wise SM, Wilson MA. A case of periostitis secondary to voriconazole therapy in a heart transplant recipient. Clin Nucl Med. 2011; 36(3):242-244.